Submission Deadline Extended to October 27, 2020
Submit Your Best Science for ISHLT2021!
On behalf of Joseph Rogers, MD, President of the International Society for Heart and Lung Transplantation, the ISHLT Board of Directors, and the ISHLT2021 Scientific Program Committee, I invite you to submit your research to be shared with peers in the Society’s 41st Annual Meeting & Scientific Sessions to be held April 27 – 30, 2021, in Toronto, Canada...and virtually
ISHLT2021 is being planned as a hybrid meeting, integrating virtual and face-to-face presentations and participation. This will allow maximum flexibility for presenters. Whether in person or online, you’ll be able to share your work internationally among the world's most influential professionals in the field of end-stage heart and/or lung failure.
The ISHLT welcomes submissions from all specialists engaged in treating advanced heart and lung disease, particularly those working on novel therapies
. We look forward to continuing to present some of the most ground-breaking investigative studies
, including sessions on COVID-19. Read More →
There are THREE areas
in which to submit an abstract:
Each abstract may be submitted in only ONE
of these areas. Submission of the same abstract into different categories is not permitted.
Submission of one study as several different abstracts is not permitted. If the abstracts in question are not distinct enough to be considered separate studies, or if the same abstract is submitted into multiple categories, all versions may be rejected.
Please review the ISHLT Abstract Submission Policies
prior to submitting your abstract.
For questions regarding tables, images and character limits, check out our Abstract FAQ.
Abstracts Accepted for ISHLT2020
If your abstract was accepted for presentation at the ISHLT2020 meeting but was never presented and has not been published as a full article, you may resubmit your abstract for consideration to the ISHLT2021 Annual Meeting. This applies to any type of abstract: Research, Late-Breaking, or Early Career Clinical Case Reports.
2020 Abstract Submission Stats